| Primary |
| Hypertension |
29.5% |
| Blood Pressure Abnormal |
9.8% |
| Anxiety |
8.2% |
| Gastritis |
6.6% |
| Blood Cholesterol Increased |
4.9% |
| Blood Triglycerides Increased |
4.9% |
| Gastritis Erosive |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Cardiac Failure |
3.3% |
| Diabetes Mellitus |
3.3% |
| Dizziness |
3.3% |
| Osteoarthritis |
3.3% |
| Breast Cancer |
1.6% |
| Computerised Tomogram |
1.6% |
| Essential Hypertension |
1.6% |
| Intraocular Pressure Test Abnormal |
1.6% |
| Mineral Supplementation |
1.6% |
| Sleep Disorder |
1.6% |
| Supplementation Therapy |
1.6% |
| Tachycardia |
1.6% |
|
| Off Label Use |
21.1% |
| Hypokalaemia |
15.8% |
| Asthmatic Crisis |
5.3% |
| Breast Cancer Female |
5.3% |
| Drug Intolerance |
5.3% |
| Essential Hypertension |
5.3% |
| Hyponatraemia |
5.3% |
| Infection |
5.3% |
| Renal Failure Acute |
5.3% |
| Restless Legs Syndrome |
5.3% |
| Skin Hyperpigmentation |
5.3% |
| Sopor |
5.3% |
| Tooth Loss |
5.3% |
| Weight Increased |
5.3% |
|
| Secondary |
| Blood Pressure Abnormal |
33.8% |
| Anxiety |
20.3% |
| Hypertension |
12.2% |
| Product Used For Unknown Indication |
6.8% |
| Supplementation Therapy |
6.8% |
| Depression |
5.4% |
| Astringent Therapy |
2.7% |
| Neuropathy Peripheral |
2.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Diabetes Mellitus |
1.4% |
| Heart Transplant |
1.4% |
| Multiple Sclerosis |
1.4% |
| Sleep Disorder |
1.4% |
| Tachycardia |
1.4% |
|
| Weight Increased |
41.7% |
| Hyponatraemia |
16.7% |
| Asthmatic Crisis |
8.3% |
| Cardiac Arrest |
8.3% |
| Hypokalaemia |
8.3% |
| Rash |
8.3% |
| Syncope |
8.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.7% |
| Hypertension |
19.7% |
| Diffuse Large B-cell Lymphoma |
12.1% |
| Depression |
6.6% |
| Diabetes Mellitus |
4.6% |
| Rheumatoid Arthritis |
3.2% |
| Osteoporosis |
2.6% |
| Sleep Disorder |
2.6% |
| Blood Cholesterol Increased |
2.3% |
| Breast Cancer |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
| Deep Vein Thrombosis |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Pain |
2.0% |
| B-cell Lymphoma |
1.7% |
| Blood Pressure |
1.7% |
| Cerebrovascular Accident |
1.7% |
| Dyspepsia |
1.7% |
| Anxiety |
1.4% |
| Atrial Fibrillation |
1.4% |
|
| Urinary Tract Infection |
9.6% |
| Weight Decreased |
7.7% |
| Dehydration |
5.8% |
| Diarrhoea |
5.8% |
| Nausea |
5.8% |
| Neutropenia |
5.8% |
| Pain In Extremity |
5.8% |
| Vomiting |
5.8% |
| Wrong Technique In Drug Usage Process |
5.8% |
| Death |
3.8% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Hallucination |
3.8% |
| Hypertension |
3.8% |
| No Therapeutic Response |
3.8% |
| Pain |
3.8% |
| Renal Impairment |
3.8% |
| Speech Disorder |
3.8% |
| Spinal Disorder |
3.8% |
| Suicide Attempt |
3.8% |
| Syncope |
3.8% |
|
